During the past decade, Piedmont Hospital Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Hospital Research Institute" #1 sponsor was "Allon Therapeutics" with 1 trials, followed by "Atrium Medical Corporation" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Hospital Research Institute" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "City of Hope National Medical Center" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Hospital Research Institute" are "Breast Cancer" (1 trials), "Congestive Heart Failure" (1 trials), "Coronary Artery Disease" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Piedmont Hospital Research Institute" in a lesser frequency.

Most popular intervention types in "Piedmont Hospital Research Institute" are "Drug" (9 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ABI-007 (Abraxane)" (1 trials), "ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)" (1 trials), "AL-208" (1 trials) and "Albumin-bound paclitaxel (ABI-007)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Hospital Research Institute" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Hospital Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Piedmont Hospital Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Hospital Research Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".